FDA product code JLZ: Nadh, Phosphoglycerate Mutase, Atp (U.V.) 2,3-Diphosphoglyceric Acid
JLZ is the FDA product code for nadh, phosphoglycerate mutase, atp (u.v.) 2,3-diphosphoglyceric acid. It is a Class I device, regulated under 21 CFR 862.1255 and reviewed by the Clinical Chemistry panel. Devices under JLZ reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Nadh, Phosphoglycerate Mutase, Atp (U.V.) 2,3-Diphosphoglyceric Acid |
| Device class | Class I |
| Regulation | 21 CFR 862.1255 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) exempt |
Recalls for JLZ devices
openFDA lists no recalls for product code JLZ.
Frequently asked questions
What is FDA product code JLZ?
JLZ is the FDA product code for nadh, phosphoglycerate mutase, atp (u.v.) 2,3-diphosphoglyceric acid. It is a Class I device, regulated under 21 CFR 862.1255 and reviewed by the Clinical Chemistry panel.
What device class is JLZ?
Class I, regulation 21 CFR 862.1255. Typical premarket route: 510(k) exempt.
Next steps
- Run an FDA pathway report with predicate devices for product code JLZ
- Run a recall and safety report across every JLZ manufacturer
- Watch product code JLZ for new clearances and recalls
Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.
All Clinical Chemistry product codes · FDA product code lookup